Accumulation of the solvent vehicle sulphobutylether beta cyclodextrin sodium in critically ill patients treated with intravenous voriconazole under renal replacement therapy

BACKGROUND: Voriconazole was introduced for the treatment of life-threatening fungal infections. The intravenous form includes the solvent vehicle sulphobutylether beta cyclodextrin sodium which shows an impaired clearance under intermittent dialysis therapy. This investigation aimed to determine fi...

Descripción completa

Detalles Bibliográficos
Autores principales: von Mach, Marc A, Burhenne, Jürgen, Weilemann, Ludwig S
Formato: Texto
Lenguaje:English
Publicado: BioMed Central 2006
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC1592308/
https://www.ncbi.nlm.nih.gov/pubmed/16981986
http://dx.doi.org/10.1186/1472-6904-6-6

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC1592308/
https://www.ncbi.nlm.nih.gov/pubmed/16981986
http://dx.doi.org/10.1186/1472-6904-6-6

Ejemplares similares